- Home
- INBX vs ITRG Comparison
INBX vs ITRG Comparison
Compare INBX & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | ITRG |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 874.5M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | INBX | ITRG |
|---|---|---|
| Price | $58.33 | $2.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | N/A | ★ $5.13 |
| AVG Volume (30 Days) | 143.2K | ★ 2.7M |
| Earning Date | 03-19-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | $51.39 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $10.81 | $1.05 |
| 52 Week High | $94.57 | $4.87 |
Technical Indicators
Market Signals| Indicator | INBX | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 33.28 | 29.62 |
| Support Level | $28.54 | $1.43 |
| Resistance Level | $85.97 | $3.24 |
| Average True Range (ATR) | 4.27 | 0.20 |
| MACD | -0.55 | -0.07 |
| Stochastic Oscillator | 8.45 | 4.44 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.